Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights.
about
Supplementing Conventional Treatment with Pycnogenol® May Improve Hepatitis C Virus-Associated Type 2 Diabetes: A Mini ReviewPurification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitorsDirect-acting antivirals for chronic hepatitis C.Phosphorylation of Serine 235 of the Hepatitis C Virus Non-Structural Protein NS5A by Multiple KinasesThe iron homeostasis network and hepatitis C virus - a new challenge in the era of directly acting antiviralsMolecular mechanism of divalent-metal-induced activation of NS3 helicase and insights into Zika virus inhibitor design.Extrahepatic manifestations of HCV: the role of direct acting antivirals.Small-molecule inhibitors of hepatitis C virus (HCV) non-structural protein 5A (NS5A): a patent review (2010-2015).A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation-and Beyond?NMR reveals the intrinsically disordered domain 2 of NS5A protein as an allosteric regulator of the hepatitis C virus RNA polymerase NS5B.Evaluation of Sofosbuvir (β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine) as an inhibitor of Dengue virus replication.Hepatitis C virus mediated chronic inflammation and tumorigenesis in the humanised immune system and liver mouse model.Epidemiologic features of 348 children with hepatitis C virus infection over a 30-year period: a nationwide survey in Japan.Impact of different sofosbuvir based treatment regimens on the biochemical profile of chronic hepatitis C genotype 4 patients.Guanine α-carboxy nucleoside phosphonate (G-α-CNP) shows a different inhibitory kinetic profile against the DNA polymerases of human immunodeficiency virus (HIV) and herpes viruses.Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A Inhibitors.Interferon-α-induced CD100 on naïve CD8+ T cells enhances antiviral responses to hepatitis C infection through CD72 signal transduction.Next-Generation Sequencing: a Diagnostic One-Stop Shop for Hepatitis C?Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.Community-based screening of hepatitis C with a one-step RNA detection algorithm from dried-blood spots: Analysis of key populations in Barcelona, Spain.The Chimpanzee Model of Viral Hepatitis: Advances in Understanding the Immune Response and Treatment of Viral Hepatitis.Biochemical Basis of Vosevi, a New Treatment for Hepatitis CPublished as part of the Biochemistry series "Biochemistry to Bedside".Hepatitis C virus core+1/ARFP modulates Cyclin D1/pRb pathway and promotes carcinogenesis.Sofosbuvir + velpatasvir + voxilaprevir for the treatment of hepatitis C infection.A novel occludin-targeting monoclonal antibody prevents hepatitis C virus infection in vitro.Development and validation of a phenotypic high-content imaging assay for assessing the antiviral activity of small-molecule inhibitors targeting the Zika virusEpidemic history of hepatitis C virus genotypes and subtypes in PortugalDirect-acting antivirals for chronic hepatitis CSequential S232/S235/S238 Phosphorylation of the Hepatitis C Virus Nonstructural Protein 5AThe osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication
P2860
Q28068362-15946FF7-5188-4499-B60A-FC54EA7482DCQ28223065-9B6F786C-E6EA-49F3-B9AE-7DD1274A7D5DQ34557595-F4092A21-1B60-4EBA-BF5B-94851669E8D7Q36201245-CDA2BF2D-AFA9-4E41-BE49-D487762B0119Q37189852-4EEFE82D-A5E6-430F-A9B3-1FB947130C03Q37473075-0704A30D-B57C-453E-A038-C2B1FC3BCB4FQ38684508-3C2A66F6-3F3C-4A4B-AF9D-12D6B210926CQ39038238-42156B38-DD87-419A-966F-8E0EA11F690FQ39322379-6BBCCF2D-F3E5-4561-89CF-327A50B29DA0Q40040199-1EDE0D6E-8BBC-448F-9E68-048BD2621ADBQ40046618-ADACCAD6-6FC2-49B4-BDCA-08D7E3B1B9EDQ40050887-F140A937-6C60-4CE5-9385-F0C9CAAE4E3DQ40178123-748F4ADD-B9B4-4C44-9B1B-4AB20A272818Q40211318-BD000401-982F-412F-836D-31678E6DFB01Q40251943-902A6085-2A7D-490F-B3D2-52F5A406B2CDQ40271353-0C49F4AF-3B1E-4DE5-8E78-4CF78016D53BQ40323617-4313A8EF-CE0F-4676-AC26-E6F62A91D719Q40627402-3259DFE3-3B46-4DCA-A0FA-1708F845085EQ43280688-0490FF13-9258-4D5B-8769-B1E45E0ECDC1Q47605695-BE35C243-68D8-402F-838E-09CDFE1E694BQ47608448-B2BC1813-CA52-45B9-9EFD-FEB30337C536Q48218532-6F596FA1-15D8-4CD2-B75F-02A5C9582D99Q50106254-CC9FB76A-7BD8-4298-B171-99C529BD3E03Q52326653-1DBD8064-A70F-47E2-B525-DE305420912FQ52571268-820536F3-14AF-4195-B195-5AF015B6963EQ56342513-E1C16644-096E-4BC9-AAFF-A621AD39B833Q56395674-CAC3D708-ACD9-434C-AFF2-316FA0B9621AQ57389418-47C981A1-52BE-481D-97B4-653770A13A92Q57469882-56160717-AB83-4354-9E41-9A5B17E99F41Q58769353-EF6B0276-F718-4075-A66D-C7015E229121
P2860
Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights.
@en
type
label
Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights.
@en
prefLabel
Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights.
@en
P2860
P356
P1476
Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights.
@en
P2093
Jordan J Feld
Matthias Götte
P2860
P2888
P304
P356
10.1038/NRGASTRO.2016.60
P407
P577
2016-05-05T00:00:00Z